BioCentury
ARTICLE | Clinical News

Methylprednisolone regulatory update

November 5, 2012 8:00 AM UTC

FDA and CDC identified bacteria contamination in lots of betamethasone and cardioplegia solution distributed by the compounding center. The agencies said the clinical significance of the results is not known. The agencies said the contamination reinforced FDA's concerns about the lack of sterility in products produced at the facility and noted providers should not use any product supplied from the pharmacy. Cardiolegia is a solution used to bathe the heart, while betamethasone is a topical steroid. ...